Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5513)
IONIS PHARMACEUTICALS INC (IONS)
BERTHELSEN SPENCER R — Director
Shares
8,000
Price
$73.49
Total Value
$587.92K
Shares Held After
156,013
% of Holdings
4.9%
Simulations Plus, Inc. (SLP)
Fiedler-Kelly Jill — President, Services Solutions
Shares
1,050
Price
$16.51
Total Value
$17.34K
Shares Held After
77,817
% of Holdings
1.3%
CG Oncology, Inc. (CGON)
Mulay James — Director
Shares
1,310
Price
$60.12
Total Value
$78.76K
Shares Held After
0
% of Holdings
100.0%
CG Oncology, Inc. (CGON)
Mulay James — Director
Shares
654
Price
$60.12
Total Value
$39.32K
Shares Held After
0
% of Holdings
100.0%
Omada Health, Inc. (OMDA)
Cook Steven L. — Chief Financial Officer
Shares
6,800
Price
$17.23
Total Value
$117.18K
Shares Held After
187,209
% of Holdings
3.5%
DENTSPLY SIRONA Inc. (XRAY)
HOSEIN CLYDE — Director
Shares
6,500
Price
$9.98
Total Value
$64.90K
Shares Held After
70,575
% of Holdings
9.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
920
Price
$553.47
Total Value
$509.20K
Shares Held After
40,513
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
760
Price
$552.59
Total Value
$419.97K
Shares Held After
41,433
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,180
Price
$551.57
Total Value
$650.85K
Shares Held After
42,193
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,768
Price
$550.72
Total Value
$973.66K
Shares Held After
43,373
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
732
Price
$549.56
Total Value
$402.28K
Shares Held After
45,141
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,459
Price
$548.53
Total Value
$800.30K
Shares Held After
45,873
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
482
Price
$547.63
Total Value
$263.96K
Shares Held After
47,332
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
470
Price
$546.22
Total Value
$256.73K
Shares Held After
47,814
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
809
Price
$545.51
Total Value
$441.32K
Shares Held After
48,284
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$543.51
Total Value
$239.14K
Shares Held After
49,093
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$541.61
Total Value
$108.32K
Shares Held After
49,533
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
205
Price
$540.43
Total Value
$110.79K
Shares Held After
49,733
% of Holdings
0.4%
SHOULDER INNOVATIONS, INC. (SI)
Ahearn Matthew Fraser — Director
Shares
2,500
Price
$19.26
Total Value
$48.15K
Shares Held After
269,176
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
75
Price
$538.85
Total Value
$40.41K
Shares Held After
49,938
% of Holdings
0.1%
SHOULDER INNOVATIONS, INC. (SI)
Ahearn Matthew Fraser — Director
Shares
1,644
Price
$18.20
Total Value
$29.92K
Shares Held After
271,676
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
598
Price
$553.76
Total Value
$331.15K
Shares Held After
18,876
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
778
Price
$553.10
Total Value
$430.31K
Shares Held After
19,474
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,144
Price
$551.91
Total Value
$631.38K
Shares Held After
20,252
% of Holdings
5.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,200
Price
$550.89
Total Value
$1.21M
Shares Held After
21,396
% of Holdings
9.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
800
Price
$549.87
Total Value
$439.90K
Shares Held After
23,596
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,616
Price
$548.64
Total Value
$886.60K
Shares Held After
24,396
% of Holdings
6.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
465
Price
$547.77
Total Value
$254.71K
Shares Held After
26,012
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
504
Price
$546.54
Total Value
$275.45K
Shares Held After
26,477
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
855
Price
$545.63
Total Value
$466.52K
Shares Held After
26,981
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
560
Price
$543.50
Total Value
$304.36K
Shares Held After
27,836
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
240
Price
$541.61
Total Value
$129.99K
Shares Held After
28,396
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
45
Price
$540.64
Total Value
$24.33K
Shares Held After
28,636
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
74
Price
$539.46
Total Value
$39.92K
Shares Held After
28,681
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
121
Price
$538.52
Total Value
$65.16K
Shares Held After
28,755
% of Holdings
0.4%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
2,067
Price
$2.22
Total Value
$4.59K
Shares Held After
19,198
% of Holdings
10.8%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
2,465
Price
$2.22
Total Value
$5.47K
Shares Held After
12,435
% of Holdings
19.8%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
2,654
Price
$2.22
Total Value
$5.89K
Shares Held After
13,412
% of Holdings
19.8%
BRUKER CORP (BRKR)
Munch Mark — EXEC VP&PRES BRUKER NANO INC.
Shares
2,000
Price
$54.76
Total Value
$109.52K
Shares Held After
128,443
% of Holdings
1.5%
Aquestive Therapeutics, Inc. (AQST)
Barber Daniel — President and CEO
Shares
25,000
Price
$4.16
Total Value
$104.01K
Shares Held After
635,574
% of Holdings
3.8%
Immuneering Corp (IMRX)
Hall Brett Matthew — CHIEF SCIENTIFIC OFFICER
Shares
6,035
Price
$4.15
Total Value
$25.05K
Shares Held After
382,531
% of Holdings
1.6%
RadNet, Inc. (RDNT)
Forthuber Stephen M — Pres & CEO-Eastern Operations
Shares
19,853
Price
$58.61
Total Value
$1.16M
Shares Held After
507,199
% of Holdings
3.8%
RadNet, Inc. (RDNT)
Forthuber Stephen M — Pres & CEO-Eastern Operations
Shares
24,214
Price
$57.79
Total Value
$1.40M
Shares Held After
527,052
% of Holdings
4.4%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
1,831
Price
$2.22
Total Value
$4.06K
Shares Held After
11,007
% of Holdings
16.6%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
2,322
Price
$72.08
Total Value
$167.36K
Shares Held After
980,073
% of Holdings
0.2%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
82,740
Price
$71.42
Total Value
$5.91M
Shares Held After
982,395
% of Holdings
7.8%
STERIS plc (STE)
Zangerle John Adam — Sr. VP, Gen Counsel, and Sec.
Shares
1,419
Price
$209.28
Total Value
$296.97K
Shares Held After
35,259
% of Holdings
3.9%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
2,118
Price
$2.22
Total Value
$4.70K
Shares Held After
11,958
% of Holdings
17.7%
Immunovant, Inc. (IMVT)
Pande Atul — Director
Shares
1,500
Price
$34.02
Total Value
$51.03K
Shares Held After
116,731
% of Holdings
1.3%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Reynoso Jamie L. — CEO, Medicare Advantage
Shares
6,350
Price
$4.61
Total Value
$29.27K
Shares Held After
2,843,571
% of Holdings
0.2%
Showing 251–300 of 5513 transactions (page 6 of 111)